RENT.COM.AU LIMITED — Capital/Financing Update 2007

Feb 1, 2007

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 177/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.

Name of entity

Select Vaccines Limited

ABN

25 062 063 692

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

• $\mathbf{1}$ ⁺Class of ⁺securities issued or to be issued
• $\overline{2}$ Number of ⁺securities issued or to be issued (if known) or maximum number which may be issued

• Principal terms of the ⁺securities 3 (eg, if options, exercise price and expiry date; if partly paid *securities, the amount outstanding and due dates for payment; if securities. ⁺convertible the conversion price and dates for conversion)

• (a) Ordinary Shares (SLT) (b) Ordinary Shares (SLT) (c) Unquoted options

• (a) $2.500.000$ (b) $2,500,000$ $(c)$ 3.000.000

(a) Pari passu with existing ordinary shares

(b) Pari passu with existing ordinary shares

(c) Exercisable at \$0.00 after average closing share price is equal or greater than \$0.06 over a period of 15 trading days expiring on 5 August 2011.

AJ-014292-22-48-VEAJ

$\epsilon$

⁺ See chapter 19 for defined terms.

	on ASX (including the securities in clause 2 if applicable)	225,832,380 23,479,265	Ordinary Shares (SLT) 4,000,000 subject tο voluntary escrow to 29 April 2007 Options exercisable at \$0.20 on or before 31 May
8	Number and class of all securities quoted	Number	+ Class
7	entering οf *securities into Dates uncertificated holdings or despatch of certificates	Friday 2 February 2007
6	Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)	Share and Option Plan. (b) In lieu of consulting fees (c) In lieu of consulting fees	(a) Consulting fees issued under the 2005 Employees', Directors' and Consultants'
5	Issue price or consideration	$(a)$ Nil $(b)$ Nil $(c)$ Nil
	If the additional securities do not rank equally, please state: the date from which they do ۰ the extent to which they participate for the ۰ next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank ۰ equally, other than in relation to the next dividend, distribution or interest payment
4	Do the securities rank equally in all respects from the date of allotment with an existing class of quoted *securities?	(a) Yes $(SLT)$ (b) Yes (SLT (c) Yes, Upon exercise

⁺ See chapter 19 for defined terms.

		Number	+ Class
9	Number and + class of. all *securities not quoted on ASX (including the securities in clause 2 if applicable)	3,520,000	Options exercisable at \$0.30 on or before 30 April 2008 (SLTAO)
		1,500,000	Options exercisable at $$0.30$ on or before $31$ May 2008 (SLTAP)
		500,000	Options exercisable at \$0.30 on or before 30 October 2008 (SLTAQ)
		2,000,000	Options exercisable at \$0.44 on or before 29 April 2009 (SLTAS)
		1,000,000	Options exercisable at \$0.435 on or before 29 April 2008 (SLTAU)
		3,000,000	Options exercisable at \$0.00 after average closing share price is equal or greater than \$0.06 over a period of 15 trading days expiring on 5 August 2011.

$10₁$ Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Unchanged

Part 2 - Bonus issue or pro rata issue

$11$ $\mathbf{I}\mathbf{s}$ security holder approval required? $12^°$ Is the issue renounceable or nonrenounceable? 13 Ratio in which the "securities will be offered $14$ ⁺Class of ⁺securities to which the offer relates AJ-014292-22-48-VEAJ

⁺ See chapter 19 for defined terms.

Appendix 3B New issue announcement

15	*Record determine date to entitlements
16	Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?
17	Policy for deciding entitlements in relation to fractions
18	Names of countries in which the entity has *security holders who will not be issue sent new documents Note: Security holders must be told how their
	entitlements are to be dealt with. Cross reference: rule 7.7.
19	Closing for οf date receipt acceptances or renunciations
20.	Names of any underwriters
21	Amount of any underwriting fee or commission
22	Names of any brokers to the issue
23	Fee or commission payable to the broker to the issue
24	οf handling Amount any fee to brokers who lodge payable acceptances or renunciations - on behalf of *security holders
25	If the issue is contingent on *security holders' approval, the date of the meeting
26	entitlement and acceptance Date form and prospectus or Product Disclosure Statement will be sent to persons entitled
27	If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders
28.
	Date rights trading will begin (if

⁺ See chapter 19 for defined terms.

applicable)

• $29$ Date rights trading will end (if applicable)
• 30 How do *security holders sell their entitlements in full through a broker?
• 31 How do "security holders sell part of their entitlements through a broker and accept for the balance?
• 32 How do *security holders dispose of their entitlements (except by sale through a broker)?

33 *Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

• 34 Type of securities (tick one)
• Securities described in Part 1 $(a)$
• $(b)$

35

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

• If the *securities are *equity securities, the names of the 20 largest holders of the additional *securities, and the number and percentage of additional *securities held by those holders
• If the "securities are "equity securities, a distribution schedule of the additional 36 *securities setting out the number of holders in the categories $1 - 1.000$ $1.001 - 5.000$ $5.001 - 10.000$ $10.001 - 100.000$

AJ-014292-22-48-VEAJ

⁺ See chapter 19 for defined terms.

$100,001$ and over

37

A copy of any trust deed for the additional *securities

⁺ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

• Number of securities for which 38 *quotation is sought
• 39 Class of *securities for which quotation is sought
• Do the *securities rank equally in all 40 respects from the date of allotment with an existing *elass of quoted *securities?

If the additional securities do not rank equally, please state:

• the date from which they do $\bullet$
• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
• the extent to which they do not rank equally, other than in relation to the next dividend. distribution or interest payment
• 41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another security, clearly identify that other security)
• Number and ⁺class of all ⁺securities 42 quoted on ASX (including the securities in clause $38$ )

Number	+ Class

⁺ See chapter 19 for defined terms.

Ouotation agreement

• $\mathbf{1}$ *Ouotation of our additional *securities is in ASX's absolute discretion. ASX may quote the *securities on any conditions it decides.
• $\overline{2}$ We warrant the following to ASX.
• $\bullet$ The issue of the *securities to be quoted complies with the law and is not for an illegal purpose.
• There is no reason why those *securities should not be granted *quotation. $\bullet$
• An offer of the "securities for sale within 12 months after their issue will $\bullet$ not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any "securities to be quoted and that no-one has any right to return any *securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the *securities be quoted.
• We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the 'securities to be quoted, it has been provided at the time that we request that the "securities be quoted.
• $\bullet$ If we are a trust, we warrant that no person has the right to return the *securities to be quoted under section 1019B of the Corporations Act at the time that we request that the *securities be quoted.
• $\overline{3}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
• $\overline{4}$ We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the *securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Date: Friday 2^nd February 2007

Sign Here:

Company Secretary

Print Name:

Phillip Hains

02/02/2007

www.thecfo.com.au

⁺ See chapter 19 for defined terms.